Bacteriological analysis of selected phenotypes of chronic rhinosinusitis with co-existing asthma, allergy and hypersensitivity to non-steroidal anti-inflammatory drugs

被引:2
作者
Stryjewska-Makuch, Grazyna [1 ]
Janik, Malgorzata A. [2 ]
Klaminska-Cebula, Hanna [3 ]
Kolebacz, Bogdan [1 ]
Scierski, Wojciech [4 ]
Lisowska, Grazyna [4 ]
机构
[1] Silesian Med Univ Katowice, Upper Silesian Med Ctr, Dept Laryngol & Laryngol Oncol, Independent Publ Res Hosp 7, 45-47 Ziolowa St, PL-40635 Katowice, Poland
[2] Univ Silesia Katowice, Fac Comp Sci & Mat Sci, Inst Comp Sci, Dept Biomed Comp Syst, Sosnowiec, Poland
[3] Silesian Med Univ Katowice, Upper Silesian Med Ctr, Microbiol Lab, Independent Publ Res Hosp 7, Katowice, Poland
[4] Silesian Med Univ Katowice, Dept Otorhinolaryngol & Oncol Zabrze, Zabrze, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2021年 / 38卷 / 01期
关键词
chronic rhinosinusitis; bacteriology; asthma; allergy; drug hypersensitivity; STAPHYLOCOCCUS-AUREUS; SUPERANTIGENS; MICROBIOLOGY; ASPIRIN; SKIN;
D O I
10.5114/ada.2021.104279
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Chronic rhinosinusitis (CRS) is one of the commonest chronic diseases. It is a systemic disease caused by many factors, including bacterial infections. There are two main types of CRS phenotypes: with polyps (CRSwNP) and without polyps (CRSsNP). Aim: Analysis of sinus mucosal microbiome in patients with CRS depending on the phenotype. Investigating a possible link between the type of bacterial flora and the coexistence of diseases present in the CRS (asthma, allergy or hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) as well as the number of performed operations. Material and methods: The authors conducted a retrospective study of the bacterial flora of the nasal cavity in patients with CRS operated endoscopically from March 2016 to June 2017. The study consisted od 222 women and 248 men. On the basis of an endoscopic examination, patients were qualified for the phenotype with or without polyps. Based on the medical interview patients were divided into group with asthma, allergy, NSAID hypersensitivity, first and repeated operations. The statistical analysis was made. Results: There is no statistically significant relationship (p = 0.8519) between the CRS penotypes. In the group with CRSsNP, a statistically significant relationship was found between the observed flora and the coexistence of asthma (p = 0.0409), a trend towards significance was also noticed in the case of allergy (p = 0.0947). There was no relationship between the flora and NSAID hypersensitivity (p = 0.7356). In the group of CRSwNP patients, no statistically significant relationship was found between the observed bacterial flora and the presence of asthma (p = 0.7393), hypersensitivity to drugs (p = 0.1509) or allergy (p = 0.7427). There is no statistical significance between the occurrence of particular flora and the multiplicity of operations in both the CRSwNP (p = 0.4609) and CRSsNP phenotypes (p = 0.2469). Conclusions: Gram-positive cocci were equally common in CRSwNP and CRSsNP. In the CRSsNP, there was a correlation between the coexistence of asthma and allergy, and the presence of Gram-positive cocci. There was no statistical significance between the occurrence of particular flora and the multiplicity of operations in both CRS phenotypes.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 50 条
  • [21] Non-steroidal anti-inflammatory drugs in Parkinson's disease
    Esposito, Ennio
    Di Matteo, Vincenzo
    Benigno, Arcangelo
    Pierucci, Massimo
    Crescimanno, Giuseppe
    Di Giovanni, Giuseppe
    EXPERIMENTAL NEUROLOGY, 2007, 205 (02) : 295 - 312
  • [22] Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention
    Maniewska, Jadwiga
    Jezewska, Dagmara
    CANCERS, 2021, 13 (04) : 1 - 18
  • [23] Non-steroidal anti-inflammatory drugs and bladder cancer prevention
    Castelao, JE
    Yuan, JM
    Gago-Dominguez, M
    Yu, MC
    Ross, RK
    BRITISH JOURNAL OF CANCER, 2000, 82 (07) : 1364 - 1369
  • [24] Investigation into the Combination of Aspirin with Non-steroidal Anti-inflammatory Drugs
    Ito, Naoko
    Yokoyama, Haruko
    Soeda, Shinji
    Suzuki, Yuji
    Ikeda, Noriyuki
    Tokuoka, Kentaro
    Watanabe, Masayuki
    Kitagawa, Yasuhisa
    Yamada, Yasuhiko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (07): : 1073 - 1077
  • [25] Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
    Meek, Inger L.
    van de laar, Mart A. F. J.
    Vonkeman, Harald E.
    PHARMACEUTICALS, 2010, 3 (07): : 2146 - 2162
  • [26] Non-steroidal anti-inflammatory drugs and bladder cancer prevention
    Castelao J.E.
    Yuan J.-M.
    Gago-Dominguez M.
    Yu M.C.
    Ross R.K.
    British Journal of Cancer, 2000, 82 (7) : 1364 - 1369
  • [27] Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer
    Fu, Xiangjie
    Tan, Tan
    Liu, Peijun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4595 - 4604
  • [28] Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review
    Nderitu, Paul
    Doos, Lucy
    Jones, Peter W.
    Davies, Simon J.
    Kadam, Umesh T.
    FAMILY PRACTICE, 2013, 30 (03) : 247 - 255
  • [29] Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs
    Maitra, Arundhati
    Bates, Sade
    Shaik, Monisha
    Evangelopoulos, Dimitrios
    Abubakar, Ibrahim
    McHugh, Timothy D.
    Lipman, Marc
    Bhakta, Sanjib
    BRITISH MEDICAL BULLETIN, 2016, 118 (01) : 145 - 155
  • [30] Analgesics, antipyretics and non-steroidal anti-inflammatory drugs in pediatric prescriptions
    Ferreira, Tania Regina
    Barberato Filho, Silvio
    Borgatto, Adriano Ferreti
    Lopes, Luciane Cruz
    CIENCIA & SAUDE COLETIVA, 2013, 18 (12): : 3695 - 3704